description
Some Wall Street analysts said Viking's experimental obesity treatment may be "best-in-class" following the release of midstage trial data.
image
{
height = 1414
url = "https://image.cnbcfm.com/api/v1/image/107378853-1709040141961-gettyimages-1665778558-img_5416-1.jpeg?v=1709305564"
width = 2121
}
link
https://www.cnbc.com/2024/03/03/weight-loss-drugs-viking-therapeutics-emerges-as-competitor.html
published_on
1709470101.000000
publisher
CNBC
title
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target